Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Agilent Technologies (A) Stock Price
Media stories about Agilent Technologies (NYSE:A) have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Agilent Technologies earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.1378762776122 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the headlines that may have effected Accern Sentiment’s analysis:
- Surgical Chips Global Market 2017: Key Players – Abbott Laboratories, Agilent Technologies, Perkinelmer, Fluidigm Corporation Illumina and More (openpr.com)
- Oracle Corporation (ORCL) Regains Attentions on Diverse News along Agilent Technologies, Inc. (A) and Discovery … – Investing News Update (investingbizz.com)
- Silver Lake to Write Biggest-Ever Check for Broadcom Deal – Bloomberg (bloomberg.com)
- Allergan plc (AGN) is at $174.92 per share and Agilent Technologies, Inc. (A) is listed at $68.37 – Stocks Gallery (stocksgallery.com)
- Lab Automation Market is Expected To Be Worth US$ 8.00 Billion Globally By 2027 (marketwatch.com)
Agilent Technologies (NYSE A) opened at $68.22 on Tuesday. The company has a market cap of $22,003.38, a price-to-earnings ratio of 29.86, a price-to-earnings-growth ratio of 2.68 and a beta of 1.27. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39. Agilent Technologies has a 1-year low of $42.92 and a 1-year high of $68.67.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the previous year, the company posted $0.49 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. equities analysts forecast that Agilent Technologies will post 2.32 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd were issued a dividend of $0.132 per share. This represents a $0.53 annualized dividend and a dividend yield of 0.77%. The ex-dividend date was Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 27.32%.
A has been the subject of a number of research analyst reports. Jefferies Group LLC restated a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 9th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a research note on Tuesday, October 31st. Robert W. Baird restated a “buy” rating and issued a $70.00 price target on shares of Agilent Technologies in a research note on Friday, October 20th. Barclays PLC restated a “buy” rating and issued a $67.00 price target on shares of Agilent Technologies in a research note on Wednesday, July 19th. Finally, Janney Montgomery Scott lifted their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Agilent Technologies presently has an average rating of “Buy” and an average target price of $65.78.
TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-agilent-technologies-a-stock-price/1684717.html.
In other news, insider Dominique Grau sold 13,007 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $62.00, for a total transaction of $806,434.00. Following the completion of the transaction, the insider now owns 60,098 shares of the company’s stock, valued at $3,726,076. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Boon Hwee Koh sold 4,500 shares of the business’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total transaction of $286,335.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 165,720 shares of company stock valued at $10,488,739.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.